In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer
By A Mystery Man Writer
Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.
Disparities in Clinical Research and Cancer Treatment
pCR Rates Following Neoadjuvant Therapy Similar Between Black and
In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer
Studies looking at impact of race on breast cancer severity and
Vital Signs: Racial Disparities in Breast Cancer Severity — United
Frontiers Identification of a centrosome-related prognostic
Racial disparities in survival outcomes among breast cancer
Invasive carcinoma of no special type - Wikipedia
Breast cancer - Wikipedia
Treatment Efficacy Score a Better Way to Predict Long-Term
Pathologic complete response and overall survival in breast cancer
Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during
Efficacy of durvalumab for early-stage triple-negative breast